Targeting strategies in cancer gene therapy

Jin-Hui Wang1, Xin-Yuan Liu

  • 1Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences, Shanghai 200031, China. xyliu@sibs.ac.cn

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica Et Biophysica Sinica
|April 4, 2003
PubMed

Insights

Targeted gene therapy improves cancer treatment by directing gene transfer to tumors, minimizing side effects and risks. Advances include novel viral and non-viral delivery systems and gene transcription regulation for enhanced efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Targeted gene delivery enhances therapeutic efficacy in cancer by minimizing off-target effects and germline transduction.
  • Systemic gene transfer necessitates precise targeting strategies for effective cancer treatment.
  • Gene therapy for malignancies can be achieved via targeted delivery or transcription control.

Purpose of the Study:

  • To review recent advancements in targeted gene delivery and transcription for cancer therapy.
  • To highlight novel viral and non-viral delivery systems for targeted gene therapy.
  • To discuss strategies for regulating therapeutic gene expression in tumor cells.

Main Methods:

  • Utilizing bifunctional crosslinkers for viral vector targeting (adenoviral, retroviral).
  • Engineering viral vectors with targeting peptides and polypeptide-binding domains.
  • Developing non-viral delivery systems like receptor-mediated DNA/liposome-DNA complexes and bacterial vehicles.
  • Employing tumor-specific promoters and regulatory systems for controlled gene transcription.
  • Developing antisense oligonucleotides, ribozymes, and DNAzymes for gene inactivation.

Main Results:

  • Demonstrated success of engineered viral vectors and non-viral agents in targeted delivery.
  • Replication-competent vectors show promise as anti-cancer agents.
  • Several targeted delivery systems are progressing through clinical trials.
  • Tissue-specific promoters enable targeted gene expression.
  • Oligonucleotide-based therapies can inactivate oncogenic genes.

Conclusions:

  • Targeted gene therapy offers a promising approach to improve cancer treatment outcomes.
  • Ongoing research and clinical trials are advancing the development of effective targeted gene delivery and transcription strategies.
  • The combination of targeted delivery and regulated gene expression holds significant potential for future cancer therapeutics.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...